BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29761309)

  • 1. Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?
    Bravo PE
    J Nucl Cardiol; 2019 Aug; 26(4):1125-1134. PubMed ID: 29761309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.
    Timmer SA; Knaapen P
    Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):95-101. PubMed ID: 23152441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.
    Aguiar Rosa S; Rocha Lopes L; Fiarresga A; Ferreira RC; Mota Carmo M
    Microcirculation; 2021 Jan; 28(1):e12656. PubMed ID: 32896949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
    Sciagrà R
    Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
    Cecchi F; Sgalambro A; Baldi M; Sotgia B; Antoniucci D; Camici PG; Sciagrà R; Olivotto I
    J Cardiovasc Transl Res; 2009 Dec; 2(4):452-61. PubMed ID: 20560003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.
    Lu DY; Yalçin H; Sivalokanathan S; Greenland GV; Vasquez N; Yalçin F; Zhao M; Valenta I; Ganz P; Pampaloni MH; Zimmerman S; Schindler TH; Abraham TP; Abraham MR
    J Nucl Cardiol; 2020 Dec; 27(6):2031-2043. PubMed ID: 30456498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography].
    Cecchi F; Olivotto I; Baldi M; Maron MS; Maron BJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1069-73. PubMed ID: 20193174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.
    Castagnoli H; Ferrantini C; Coppini R; Passeri A; Baldini K; Berti V; Cecchi F; Olivotto I; Sciagrà R
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2413-2422. PubMed ID: 27527796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.
    Yalcin H; Valenta I; Zhao M; Tahari A; Lu DY; Higuchi T; Yalcin F; Kucukler N; Soleimanifard Y; Zhou Y; Pomper MG; Abraham TP; Tsui B; Lodge MA; Schindler TH; Roselle Abraham M
    J Nucl Cardiol; 2019 Aug; 26(4):1243-1253. PubMed ID: 29359273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography to assess the haemodynamics of the coronary circulation.
    Camici PG
    Semin Interv Cardiol; 1998 Mar; 3(1):31-8. PubMed ID: 10094182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular dysfunction in hypertrophic cardiomyopathy detected by Rubidium-82 positron emission tomography and cardiac magnetic resonance imaging.
    Moody WE; Schmitt M; Arumugam P
    J Nucl Cardiol; 2019 Apr; 26(2):666-670. PubMed ID: 29516367
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences.
    Olivotto I; Cecchi F; Camici PG
    Ital Heart J; 2004 Aug; 5(8):572-80. PubMed ID: 15554027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
    Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of evaluating coronary atherosclerosis in adult patients with hypertrophic cardiomyopathy who have chest pain.
    Shin YJ; Lee JH; Yoo JY; Kim JA; Jeon Y; Yoon YE; Chun EJ
    Eur Radiol; 2019 Sep; 29(9):4593-4602. PubMed ID: 30796567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked multi-distribution myocardial ischemia in a patient with hypertrophic cardiomyopathy and no obstructive coronary artery disease.
    Chan N; Kataria V; Delphin J; Auerbach A; Makaryus JN
    J Nucl Cardiol; 2020 Apr; 27(2):695-697. PubMed ID: 30719657
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of myocardial blood flow and myocardial flow reserve with SPECT imaging technique.
    Khaing T; Raymond CCW; Chan WX; Hao C; Wong SS
    J Nucl Cardiol; 2019 Feb; 26(1):318-323. PubMed ID: 29352374
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.
    Feher A; Sinusas AJ
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical topic: Nuclear imaging in hypertrophic cardiomyopathy.
    Delgado V; Bax JJ
    J Nucl Cardiol; 2015 Jun; 22(3):408-18. PubMed ID: 25548121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.